Cell and gene therapies are opening new chapters for treating disease. By working with living cells and fine-tuning their ...
Companies are adopting diverse approaches to reducing unwanted toxicities associated with cell and gene therapy.
A new platform identifies which genes drive particle assembly to engineer cells that yield more potent delivery vehicles.
CRISPR-based modification of haematopoietic stem cells has enabled durable, boostable antibody production in mouse models ...
Two papers published in The New England Journal of Medicine highlight the potential of gene editing for treatment of sickle ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its ...
Gene editing has emerged as a powerful approach for targeting the genetic causes of disease, but getting the editing ...
Re: “Genetic modification is old news,” letter, Aug. 13; “All of us are genetically modified organisms,” letter, Aug. 14. I am deeply concerned about the level of misunderstanding regarding GMOs.
A robust and quantitative map links chromatin modification and gene expression of cells during zebrafish embryogenesis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results